Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk

被引：0
|
作者：
Richard Allman
Yi Mu
Gillian S. Dite
Erika Spaeth
John L. Hopper
Bernard A. Rosner
机构：
[1] Genetic Technologies Limited,Channing Division of Network Medicine
[2] Brigham and Women’s Hospital and Harvard Medical School,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health
[3] Phenogen Sciences Inc,undefined
[4] The University of Melbourne,undefined
来源：
Breast Cancer Research and Treatment | 2023年 / 198卷
关键词：
Risk prediction model; Polygenic risk; Mammographic density;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：335 / 347
页数：12
相关论文
共 50 条
  • [31] Mammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer
    Lusine Yaghjyan
    Graham A. Colditz
    Bernard Rosner
    Rulla M. Tamimi
    Cancer Causes & Control, 2012, 23 : 785 - 790
  • [32] Mammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer
    Yaghjyan, Lusine
    Colditz, Graham A.
    Rosner, Bernard
    Tamimi, Rulla M.
    CANCER CAUSES & CONTROL, 2012, 23 (05) : 785 - 790
  • [33] Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction
    Lee, Charmaine Pei Ling
    Choi, Hyungwon
    Soo, Khee Chee
    Tan, Min-Han
    Chay, Wen Yee
    Chia, Kee Seng
    Liu, Jenny
    Li, Jingmei
    Hartman, Mikael
    PLOS ONE, 2015, 10 (09):
  • [34] Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model
    Mavaddat, Nasim
    Ficorella, Lorenzo
    Carver, Tim
    Lee, Andrew
    Cunningham, Alex P.
    Lush, Michael
    Dennis, Joe
    Tischkowitz, Marc
    Downes, Kate
    Hu, Donglei
    Hahnen, Eric
    Schmutzler, Rita K.
    Stockley, Tracy L.
    Downs, Gregory S.
    Zhang, Tong
    Chiarelli, Anna M.
    Bojesen, Stig E.
    Liu, Cong
    Chung, Wendy K.
    Pardo, Monica
    Feliubadalo, Lidia
    Balmana, Judith
    Simard, Jacques
    Antoniou, Antonis C.
    Easton, Douglas F.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (03) : 422 - 427
  • [35] Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk
    Kalia, Sarah S.
    Boddicker, Nicholas J.
    Yadav, Siddhartha
    Huang, Hongyan
    Na, Jie
    Hu, Chunling
    Ambrosone, Christine B.
    Yao, Song
    Haiman, Christopher A.
    Chen, Fei
    John, Esther M.
    Kurian, Allison W.
    Guo, Boya
    Lindstrom, Sara
    Auer, Paul
    Lacey, James V.
    Neuhausen, Susan L.
    Martinez, Maria Elena
    Sandler, Dale P.
    O'Brien, Katie M.
    Taylor, Jack A.
    Teras, Lauren R.
    Hodge, James M.
    Lori, Adriana
    Bodelon, Clara
    Trentham-Dietz, Amy
    Burnside, Elizabeth S.
    Vachon, Celine M.
    Winham, Stacey J.
    Goldgar, David E.
    Domchek, Susan M.
    Nathanson, Katherine L.
    Weitzel, Jeffrey N.
    Couch, Fergus J.
    Kraft, Peter
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (11) : 1490 - 1499
  • [36] Mammographic density as risk factor for breast cancer
    Macchetti, Alexandre Henrique
    Cosiski Marana, Heitor Ricardo
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2007, 29 (10): : 493 - 496
  • [37] Mammographic Density as a Marker of Breast Cancer Risk?
    Tice, Jeffrey A.
    CURRENT BREAST CANCER REPORTS, 2009, 1 (03) : 175 - 180
  • [38] Mammographic density as a risk factor for breast cancer
    Fulton, Loralee
    Reynolds, Diane
    Flom, Julie
    Terry, MaryBeth
    ONCOLOGY NURSING FORUM, 2008, 35 (03) : 516 - 517
  • [39] Mammographic Density for Personalized Breast Cancer Risk
    Kataoka, Masako
    RADIOLOGY, 2023, 306 (02)
  • [40] Mammographic Density Change and Risk of Breast Cancer
    Azam, Shadi
    Eriksson, Mikael
    Sjolander, Arvid
    Hellgren, Roxanna
    Gabrielson, Marike
    Czene, Kamila
    Hall, Per
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (04): : 391 - 399
12345